Home/Filings/4/0001104659-20-056160
4//SEC Filing

Stephan Dietrich A 4

Accession 0001104659-20-056160

CIK 0001173281other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 3:25 PM ET

Size

16.8 KB

Accession

0001104659-20-056160

Insider Transaction Report

Form 4
Period: 2020-04-30
Transactions
  • Purchase

    Common Stock

    2020-04-30$6.00/sh+10,000$60,00010,000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,547,639
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2020-04-30$6.00/sh+10,000$60,00010,000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,547,639
Footnotes (2)
  • [F1]Shares held by Dietrich Stephan as a tenant by the entirety with his spouse.
  • [F2]Shares held directly by Lipizzaner LLC, of which Dr. Stephan is the sole member.

Issuer

NeuBase Therapeutics, Inc.

CIK 0001173281

Entity typeother

Related Parties

1
  • filerCIK 0001774588

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 3:25 PM ET
Size
16.8 KB